FDA Approves VPRIV to Treat Gaucher Disease
Links shared publicly online about this topic.
- 1,350total visits
FDA Approves VPRIV to Treat Gaucher Disease
View full resource at drugs.com
Tags: Lipid Storage Disease, Gaucher Disease, Disease and Condition, FDA
Most Recently Shared on February 28, 2010 at 5:02 am By:
FDA Approves VPRIV to Treat Gaucher Disease - http://bit.ly/dATgn7
Shire receives approval for VPRIV to treat type 1 Gaucher disease
news-medical.net — “Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on August 27, 2010 at 10:15 am By:
Shire receives approval for VPRIV to treat type 1 Gaucher disease: Shire, the global specialty biopharmaceutical c... http://bit.ly/d0YvUf
Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) For The Treatment Of Type 1 Gaucher Disease
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human ce” View full resource at medicalnewstoday.com
Most Recently Shared on May 29, 2010 at 1:06 pm By:
Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) For The Treatment Of Type 1 Gaucher Disease http://mnt.to/3Dhn
Vpriv available for Type 1 Gaucher disease - ONA
oncologynurseadvisor.com — “Shire announced that Vpriv (velaglucerase alfa for injection) has been FDA approved and made available for the treatment of Type 1 Gaucher disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 1, 2010 at 4:13 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Vpriv available for Type 1 Gaucher disease http://goo.gl/fb/3kQb
Replacement Therapy Approved for Gaucher Disease - Drugs.com MedNews
drugs.com — “Velaglucerase alfa for injection (VPRIV) has been approved by the U.S. Food and Drug Administration to treat a rare inherited disorder called Gaucher disease, t” View full resource at drugs.com
Most Recently Shared on February 28, 2010 at 4:29 am By:
Replacement Therapy Approved for Gaucher Disease - http://bit.ly/9m1onF
FDA Approves Therapy To Treat Gaucher Disease
tweetmeme.com — “The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease. Gaucher disease occurs in people who do not produce enough of an enzy” View full resource at tweetmeme.com
Most Recently Shared on February 27, 2010 at 2:49 pm By:
Healthcare TweetMeme Health Social Media
FDA Approves Therapy To Treat Gaucher Disease http://retwt.me/1MjGN (via @healthytweet)
Gaucher disease: FDA approves VPRIV
news-medical.net — “The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on February 27, 2010 at 4:57 am By:
Stroke News: Gaucher disease: FDA approves VPRIV: The U.S. Food and Drug Administration has approved velaglucera... http://twurl.nl/zaidct
FDA formally approves new drug for Gaucher disease | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The Food and Drug Administration on Friday formally approved a new drug called velaglucerase alfa for injection (tradenamed VPRIV) for treatment of the rare genetic disorder Gaucher disease. The agency has already been allowing the company to ship the drug...” View full resource at latimesblogs.latimes.com
Most Recently Shared on February 26, 2010 at 11:27 pm By:
LA Times Health News Health News
FDA formally approves new drug for Gaucher disease http://bit.ly/9Dy9gD
Advertisement
